Signaling Pathway
Lofacimig is a bispecific antibody designed as a VH-VH-G1(h-CH2-CH3) dimer, specifically targeting FXI and PTA. This configuration enhances its specificity and efficacy in engaging these particular antigens, making it a valuable tool for research into coagulation and anticoagulation pathways.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Lofacimig is a bispecific antibody designed as a VH-VH-G1(h-CH2-CH3) dimer, specifically targeting FXI and PTA. This configuration enhances its specificity and efficacy in engaging these particular antigens, making it a valuable tool for research into coagulation and anticoagulation pathways. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
